Circulating Tumor DNA in Primary Mediastinal Large B-cell Lymphoma (PMBL)
Condition(s):Primary Mediastinal Large B-cell LymphomaLast Updated:April 1, 2021Recruiting
Hide Studies Not Open or Pending
Condition(s):Primary Mediastinal Large B-cell LymphomaLast Updated:April 1, 2021Recruiting
Condition(s):Resectable Pancreatic CancerLast Updated:January 4, 2023Completed
Condition(s):Hepatocellular CarcinomaLast Updated:May 20, 2022Not yet recruiting
Condition(s):Circulating Tumor DNA (ctDNA); Gastric CancerLast Updated:April 28, 2022Recruiting
Condition(s):Locally Advanced Rectal Carcinoma; Circulating Tumor DNALast Updated:November 1, 2022Recruiting
Condition(s):Esophageal Cancer; Gastric CancerLast Updated:October 6, 2020Recruiting
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:July 30, 2020Unknown status
Condition(s):Soft Tissue SarcomaLast Updated:January 10, 2023Recruiting
Condition(s):Lung Neoplasms; Lung Cancer; Neoplasm of Lung; Non Small Cell Lung CancerLast Updated:February 18, 2021Completed
Condition(s):Gastric Cancer; Circulating Tumor DNA (ctDNA)Last Updated:August 24, 2022Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.